# Drug Development
Latest news and articles about Drug Development
Total: 3 articles found
Bio-Silicon Ambitions: China Establishes National Standards for Vascular-on-a-Chip Technology
China has introduced its first national technical standards for vascular-on-a-chip technology, effective 2027, aiming to standardize the biomanufacturing of 3D microfluidic vascular models. This regulatory milestone seeks to move the industry from experimental lab work to standardized applications in drug R&D and toxicology, reducing reliance on animal testing.
Nona Biosciences Bolsters Global R&D Edge with Appointment of Shouhua Xiao as Chief Scientific Officer
Nona Biosciences has appointed Dr. Shouhua Xiao as CSO to drive its scientific strategy and enhance its 'Idea to IND' antibody discovery services. The move underscores the company's global ambitions and its focus on translating proprietary platform technologies into clinical successes.
AbbVie Taps Chinese Innovation in $745 Million Bet on Next-Generation Pain Relief
Haisco Pharmaceutical has signed a global licensing deal with AbbVie for its Nav1.8 pain inhibitor, worth up to $745 million. The agreement grants AbbVie exclusive rights outside of Greater China and highlights the shift toward Chinese-developed innovative therapies in the global market.